Cite
Alosaimy S, Lagnf AM, Morrisette T, et al. Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant . Open Forum Infect Dis. 2021;8(8):ofab371doi: 10.1093/ofid/ofab371.
Alosaimy, S., Lagnf, A. M., Morrisette, T., Scipione, M. R., Zhao, J. J., Jorgensen, S. C. J., Mynatt, R., Carlson, T. J., Jo, J., Garey, K. W., Allen, D., DeRonde, K., Vega, A. D., Abbo, L. M., Venugopalan, V., Athans, V., Saw, S., Claeys, K. C., Miller, M., Molina, K. C., Veve, M., Kufel, W. D., Amaya, L., Yost, C., Ortwine, J., Davis, S. L., & Rybak, M. J. (2021). Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant . Open forum infectious diseases, 8(8), ofab371. https://doi.org/10.1093/ofid/ofab371
Alosaimy, Sara, et al. "Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant ." Open forum infectious diseases vol. 8,8 (2021): ofab371. doi: https://doi.org/10.1093/ofid/ofab371
Alosaimy S, Lagnf AM, Morrisette T, Scipione MR, Zhao JJ, Jorgensen SCJ, Mynatt R, Carlson TJ, Jo J, Garey KW, Allen D, DeRonde K, Vega AD, Abbo LM, Venugopalan V, Athans V, Saw S, Claeys KC, Miller M, Molina KC, Veve M, Kufel WD, Amaya L, Yost C, Ortwine J, Davis SL, Rybak MJ. Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant . Open Forum Infect Dis. 2021 Jul 14;8(8):ofab371. doi: 10.1093/ofid/ofab371. eCollection 2021 Aug. PMID: 34430671; PMCID: PMC8378588.
Copy
Download .nbib